Researchers report that targeting inflammation may offer a new way to treat depression. The study focused on people with depression who had high levels of inflammation. The team reviewed clinical trials in which participants received anti-inflammatory drugs or a placebo.
Overall, anti-inflammatory treatments reduced depressive symptoms and eased anhedonia, the inability to feel pleasure. The analysis also found no increase in serious side effects among people who received the drugs.
The authors noted these drugs are not approved by the FDA to treat depression, so psychiatric use would be off-label. One co-author said the result may make immunopsychiatry more relevant and could explain earlier mixed findings when studies did not select people by inflammatory status.
Difficult words
- inflammation — body reaction that causes redness or swelling
- anhedonia — not being able to feel pleasure
- placebo — a fake medicine given in a study
- clinical trial — a medical study that tests treatmentsclinical trials
- side effect — an unwanted medical problem from a drugside effects
- immunopsychiatry — study of immune system links to mental illness
- off-label — use of a drug not officially approved
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Related articles
Heat and Young Children’s Development
New research links high temperatures to slower early childhood development. The study compared child development records with local monthly temperatures and found higher heat is associated with lower literacy and numeracy milestone attainment.
Documentary on Igor Kon wins Artdocfest prize
A new film about Igor Kon, the first Soviet sexologist, won the best director prize at Artdocfest in March 2025. The documentary was made by Berlin-based Narra and the cooperative Bereg and released on Meduza's YouTube channel.
Why people share fake news on social media
A new study explains how emotional cues make people accept and share fake news. Researchers made a model and tested it on tweets about COVID-19; they suggest platforms and schools can help reduce this problem.
Antibody and EGFR–STAT1 pathway point to new fibrosis treatments
Researchers at Yale found a human antibody that blocks epiregulin and lowers fibrosis markers. They also show EGFR activates STAT1 in fibroblasts, suggesting two treatment paths: block epiregulin or target the EGFR–STAT1 pathway.
Nasal nanomedicine clears deadly brain tumours in mice
Researchers used spherical nucleic acids given through the nose to deliver a STING-activating therapy that eradicated glioblastoma in mice and produced long-term immunity. The study appears in PNAS.
Gene Variant Raises Heart Failure Risk After Myocarditis in Children
A study found that a cardiomyopathy gene variant is more common in children who develop dilated cardiomyopathy after myocarditis. Researchers describe a "double hit" model and advise genetic testing to identify higher risk.